Rosacea

Optimize Acids, Peels in Acne Scar Treatment
July 26, 2022

An expert offers insights into the who, how, and when of these combined therapies.

Adolescent Rosacea in Peer-Reviewed Publications and Use of the 2017 National Rosacea Society Updated Guidelines
July 10, 2022

At the SPD 2022 47th Annual Meeting, a poster session looks at the updated guidelines for rosacea, and whether they are inclusive of children.

Hot Topics at the SPD 2022 47th Annual Meeting
July 03, 2022

From pediatric dermatology quizzes to the latest news in telederm to practical pearls on atopic dermatitis, alopecia, and vitiligo, there’s a lot going on at the SPD 2022 47th Annual Meeting, this year in Indianapolis, Indiana.

Rosacea Recap: Comparing Treatment Options
June 06, 2022

James Q. Del Rosso, DO, highlights different rosacea treatment options in his session at the 2022 Fall Clinical Dermatology Conference for PAs & NPs.

Rosacea Recap: The Science and the Symptom
June 06, 2022

In a session for the 2022 Fall Clinical Dermatology Conference for PAs & NPs, held June 3 to 5, in Scottsdale, Arizona, James Q. Del Rosso, DO, delves into new knowledge on the characteristics of this challenging skin condition.

Study Invites Second Look at Carvedilol
May 04, 2022

In vitro and in vivo research sheds light on medication’s mechanism of action.

Comments on the Epsolay FDA Approval for Rosacea
May 02, 2022

Julie Harper, MD, talks about the Epsolay drug approval that happened April 25. She dives into its mechanism of action, its potential as both a first line treatment or combination therapy, and what she would like to see next in its research.

Acne and Rosacea Treatment Pearls
May 01, 2022

Gina Mangin, PA-C, and James Treat, MD, dive into the intricacies of acne and rosacea, going beyond the surface of both skin conditions and giving important treatment tips at the 2022 New Wave Dermatology Conference.

Epsolay Receives FDA Approval
April 28, 2022

Sol-Gel Technologies and Galderma announce the FDA approval of the 5% benzoyl peroxide, cream for the treatment of inflammatory lesions of rosacea.

Drug Watch: What's Coming in the Rosacea Pipeline
March 10, 2022

Dermatology Times® interviews editorial board member Richard Gallo, MD, PhD, who dives into what is currently lacking is rosacea patient care, how the new mechanisms of action of these potential treatments will better address current struggles, and more.